Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Biomedicines|February 25, 2023
Simultaneous Quantification of Ivacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis Patients' Plasma by a Novel LC-MS/MS MethodFederica Pigliasco, Alessia Cafaro, Manuela Stella, et al.
Epilepsia Open|September 12, 2025
Long-term plasma monitoring of THC and CBD in pediatric drug-resistant epilepsy: Implications for cannabidiol therapy with Epidyolex®Alessia Cafaro, Antonella Riva, Federica Pigliasco, et al.
The Oncologist|February 13, 2025
Detection of plasma circulating GD2 ganglioside in patients with neuroblastoma and age-matched healthy children. Diagnostic and prognostic evaluationMartina Morini, Sebastiano Barco, Martina Ardito, et al.
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
UHPLC-MS/MS Analysis of Cannabidiol and Its Metabolites in Serum of Patients with Resistant Epilepsy Treated with CBD FormulationsSara Malaca, Massimo Gottardi, Federica Pigliasco, et al.
Journal of Clinical Medicine|March 17, 2025
A Real-Life Study of Prolonged Meropenem Infusion in Neonates and Children Admitted to Intensive Care Units: Are Three Hours Long Enough?Marcello Mariani, Marco Scaglione, Chiara Russo, et al.
Epilepsia Open|September 19, 2024
A VAMS-based LC-MS/MS method for precise cenobamate quantification in epilepsy (patients)Federica Pigliasco, Alessia Cafaro, Sebastiano Barco, et al.
Therapeutic Drug Monitoring|May 28, 2026
"Standard" Is More Than Enough: Therapeutic Drug Monitoring Confirms Early Target Attainment of Teicoplanin Regimens in Pediatric PatientsMarcello Mariani, Alessia Cafaro, Silvia M Orsi, et al.
Frontiers in Pharmacology|November 10, 2022
Cannabidiol, ∆<sup>9</sup>-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patientsFederica Pigliasco, Sara Malaca, Alfredo Fabrizio Lo Faro, et al.
Frontiers in Pharmacology|June 22, 2026
Precision management of cenobamate in drug-resistant epilepsy: integrating pharmacogenetics, therapeutic drug monitoring, and real-world clinical strategiesGiuseppe d'Orsi, Maria Teresa Di Claudio, Alessia Cafaro, et al.
Microorganisms|March 27, 2025
Etiology and Oral Antibiotic Susceptibility Patterns of the First Urinary Tract Infection Episode in Infants Under 6 Months of Age: A 17-Year, Retrospective, Single-Center Study in ItalyFrancesca Bagnasco, Francesca Lorenzini Ceradelli, Alessio Mesini, et al.
Pageof 4